Restoration of donor chimerism by nilotinib in a chronic myeloid leukaemia patient post mutation-associated imatinib mesylate resistance and allogeneic stem cell transplant failure

MeSH terms

• Antineoplastic Agents / therapeutic use*
• Benzamides
• Drug Resistance, Neoplasm / genetics
• Hematopoietic Stem Cell Transplantation
• Humans
• Imatinib Mesylate
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
• Lymphocyte Transfusion
• Male
• Middle Aged
• Neoplasm Recurrence, Local / drug therapy*
• Piperazines / therapeutic use*
• Pyrimidines / therapeutic use*
• Transplantation Chimera*
• Transplantation, Homologous